The Biden administration last month unveiled plans to start offering COVID-19 booster shots to all Americans beginning on Sept. 20. But officials are reportedly now weighing whether this plan will have to be scaled back.
Top health officials are urging the White House to scale back the COVID-19 booster shot plan because more time is needed to review the data, The New York Times reported. CNN also reported that the Biden administration is discussing whether to scale the plan back, citing an official as saying the FDA doesn't currently have enough data to recommend a third dose of the Moderna vaccine. "The officials warned that more time may be needed before enough data is in to recommend boosters for all adults," CNN writes. Data that Moderna recently submitted was "found inadequate and needs strengthening," an official said, NBC News reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Amazon's 'James Bond' deal could mean a new future for 007In the Spotlight The franchise was previously owned by the Broccoli family
-
Why are Republicans suddenly panicking about DOGE?TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
-
What is JD Vance's Net Worth?In Depth The vice president is rich, but not nearly as wealthy as his boss and many of his boss' appointees
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
HMPV is spreading in China but there's no need to worryThe Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDAIn the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
